Birdotech

BirdoTech is a state-of-the-art CRO/CDMO. We are committed to providing the highest quality services to drug discovery companies addressing worldwide healthcare needs. While partnering with the world’s top pharmaceuticals companies and institutes, we have been rigorously tested to meet time sensitive deadlines supporting critical clinical trials. We leverage our significant scientific foundation to maximize the collaborative value with our partners.

With 20,000m2 of R&D laboratory space distributed over 3 sites throughout China, our partners gain the maximum flexibility in utilising our services in medicinal chemistry SAR development, synthetic route scouting, process optimization, and production to multi-ton scale. Our success comes from our pursuit of ever more stringent scientific demands. Every challenge is an opportunity to show our commitment to our partner's success.


About BirdoTech
BirdoTech Chongqing Manufacturing Site

Our Locations/Distributions

Our History

2024

•Obtained the CNAS Laboratory Accreditation Certificate

•Opening of Chongqing c-GMP Plant

2023

•EcoVadis bronze medal for sustainability achievement

•First batch of patent operating units in Shanghai

2022

•Chongqing CDMO base started construction

2021

•Set up subsidiary in US (R&D center)

2020

•Set up subsidiary in Chongqing (R&D center)

•Set up subsidiary in Chongqing (CDMO)

•Set up 2nd R&D center in Shanghai

2019

•Set up subsidiary in Europe (Business center)

•Become a member of German Network for Pharma Solutions

2018

•Passed High-tech enterprise certification

•Passed ISO9001 certification

2017

•Set up subsidiary in Xi'an (R&D center)

2016

•Establish cooperation with the top 10 pharmaceutical companies

2015

•Set up Birdotech

•Set up Abovchem to expand international market